Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence.
Fiche publication
Date publication
mai 2018
Journal
Breast cancer research and treatment
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CHAIGNEAU Loïc, Pr NERICH Virginie, Dr PAGET-BAILLY Sophie
Tous les auteurs :
Pourcelot C, Orillard E, Nallet G, Dirand C, Billion-Rey F, Barbier G, Chouk S, Limat S, Montcuquet P, Henriques J, Paget-Bailly S, Anota A, Chaigneau L, Nerich V
Lien Pubmed
Résumé
The aim of this study was to determine the prevalence of adherence to adjuvant hormonal therapy (AHT) and to identify risk factors for medication non-adherence in clinical practice in patients with early-stage hormone receptor (HR)-positive breast cancer (BC) previously treated with chemotherapy.
Mots clés
Adjuvant hormonal therapy, Aromatase inhibitors, Breast cancer, Medication adherence, Tamoxifen
Référence
Breast Cancer Res. Treat.. 2018 May;169(1):153-162